Login

RICHARD ANDREWS President and CEO of CartoCanada Inc 00:10:00

Share On Facebook Share On Twitter

RICHARD ANDREWS President and CEO of CartoCanada Inc

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Attacq's Strategic Partnerships and Growth Initiatives: Pioneering New Horizons in Property Development|CEO, Attacq Limited
00:00:00
Understand the circuitry of the mammalian cerebral cortex / Richard Born, MD Professor of Neurobiology, HMS
00:10:00
Colombia's Miraflores Gold Project: Transformative Potential in Emerging Mining Landscape
00:10:00
The Future of Work: Insights from ASGN CEO Ted Hanson | Theodore Hanson - CEO of ASGN Incorporated
00:10:00
CEO Thomas Olin on Innovation and Biopharma Advances | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
CEO and Founder of Aritzia Shares His Journey with Bill Good | Brian Hill, CEO, Aritzia.
00:10:00
Michael Vodicka analyzes Diodes, Inc. (DIOD) for its semiconductor prospects and Central Garden & Pet Company for its position in the consumer goods market.|Keh-Shew Lu. Chairman and Chief Executive Officer of Diodes, Inc
00:10:00
Ole Kristian Jødahl, CEO of Alimak Group (ALIG), features in VD-interviews on Investor Relations.|OLE KRISTIAN JØDAHL is PRESIDENT AND CEO Alimak Group
00:10:00
New Stable Points in Venture|Frank Rotman,Cofounder, QED Investors
00:10:00
The competition among social networks to roll out audio formats|Austin Petersmith,General Partner,Coughdrop Capital
00:10:00
The North Star metric for Langchain is essentially developer productivity|Ali Rohde,Co-Founder and General Partner,Outset Capital
00:10:00
Heinrich Miller Discusses Jangada Mines' PGM Project at One-to-One Investment Conference

© 2026 Nehu